Table 2.
Sample* | Number of somatic SNVs | Number of Mutations/ Mb |
Annotation of Somatic SNVs | Number of shared somatic SNVs | % of shared SNVs | ||
---|---|---|---|---|---|---|---|
Exonic | Intronic | ||||||
Total | Non-synonymous | ||||||
1084_P0 | 4056 | 1.35 | 37 | 25 | 854 | 228 | 5.6% |
1084_T0 | 6070 | 2.02 | 77 | 59 | 1950 | 3.8% | |
1249_P0 | 4142 | 1.38 | 39 | 27 | 897 | 387 | 9.3% |
1249_T0 | 1120 | 0.37 | 13 | 10 | 288 | 34.6% | |
1494_P0 | 3433 | 1.14 | 22 | 11 | 783 | 262 | 7.6% |
1494_T0 | 1271 | 0.42 | 18 | 11 | 392 | 20.6% | |
1524_P0 | 4771 | 1.59 | 39 | 23 | 1090 | 281 | 5.9% |
1524_T0 | 2841 | 0.95 | 37 | 23 | 840 | 9.9% | |
065_P0 | 3857 | 1.29 | 38 | 24 | 897 | – | – |
098_P0 | 5637 | 1.88 | 47 | 28 | 1356 | – | – |
* T0 tumour, P0 plasma, * Patients with breast cancer - 1084, 1249, 1494 and 1524; patients with benign tumours - 065 and 098